LKT Labs

Biochemicals for Life Science Research

Masitinib

Masitinib

Product ID M0374
Cas No. 790299-79-5
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $55.10 In stock
25 mg $165.40 In stock
100 mg $529.20 In stock
Bulk Quote

Quicklinks

Description

Masitinib is an anticancer chemotherapeutic and anti-inflammatory compound used in veterinary medicine. Masitinib inhibits c-Kit and PDGFR, increasing survival time in the treatment of mast cell tumors and other cancers. In vitro, masitinib increases levels of caspases 3 and 7, inducing apoptosis. Masitinib also decreases airway inflammation and edema in feline allergic asthma models and also decreases the patient-rated severity of multiple sclerosis in clinical settings. Masitinib also exhibits potential efficacy against Alzheimer’s disease when given as an adjunct therapy, slowing cognitive decline.

Product Info

Cas No.

790299-79-5
Purity

≥98%
Formula

C28H30N6OS
Formula Wt.

498.64
Chemical Name

4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide
IUPAC Name

4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1, 3-thiazol-2-yl)amino]phenyl]benzamide
Synonym

AB1010; Masatinib; Masitinib (AB1010); Masivet 
Appearance

Gray to off white powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

M0374 MSDS PDF
Info Sheet

M0374 Info Sheet PDF

References

Smrkovski OA, Essick L, Rohrbach BW, et al. Masitinib mesylate for metastatic and non-resectable canine cutaneous mast cell tumours. Vet Comp Oncol. 2013 Jul 12. [Epub ahead of print]. PMID: 23845124.

Fahey CE, Milner RJ, Kow K, et al. Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells. Anticancer Drugs. 2013 Jun;24(5):519-26. PMID: 23466652.

Vermersch P, Benrabah R, Schmidt N, et al. Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study. BMC Neurol. 2012 Jun 12;12:36. PMID: 22691628.

Lee-Fowler TM, Guntur V, Dodam J, et al. The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma. Int Arch Allergy Immunol. 2012;158(4):369-74. PMID: 22487554.

Cadot P, Hensel P, Bensignor E, et al. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial. Vet Dermatol. 2011 Dec;22(6):554-64. PMID: 21668810.

Piette F, Belmin J, Vincent H, et al. Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial. Alzheimers Res Ther. 2011 Apr 19;3(2):16. PMID: 21504563.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T3098

    Thymosin β-4 Acetate

    Endogenous peptide; actin polymerization inhibitor...
    ≥95%
  • P0370

    Paromomycin Sulfate

    Aminoglycoside; protein translation inhibitor, cat...
    ≥98%
  • L8278

    Luteinizing Hormone Releasing Hormone, salmon

    Endogenous peptide hormone, involved in secretion ...
    ≥95%
  • C1648

    α-Cembrenediol

    Diterpene found in Anisomeles.
    ≥99%
  • D3356

    Diosmetin

    O-methylated flavone found in vetch and various fr...
    ≥98%
  • A0963

    Adrenocorticotropic Hormone (1-10), human

    Endogenous peptide hormone fragment, involved in s...
    ≥95%
  • P1765

    Peptide Standard 1

    For use in amino acid analysis.
    ≥95%
  • S8006

    Substance P (1-4)

    Endogenous tachykinin peptide, involved in inflamm...
    ≥95%
  • G2870

    Growth Hormone Releasing Factor (1-44), human

    Endogenous peptide hormone, involved in growth hor...
    ≥95%
  • I7559

    Isoliquiritigenin, natural

    Chalcone; SIRT activator, GABA-A positive modulato...
    ≥99%
  • C8112

    CUDC-907

    PI3K and HDAC inhibitor.
    ≥98%
  • L0109

    Lactalbumin

    Found in milk and whey, cation and fatty acid chel...
    ≥80%
  • P3568

    Pirarubicin

    Anthracycline, DNA intercalator; topoisomerase II ...
    ≥90%
  • N1987

    Neuropeptide Y (13-36), human

    Endogenous peptide neurotransmitter, involved in f...
    ≥95%
  • H189921

    1,2,3,4,5,6-Hexabromocyclohexane

    1,2,3,4,5,6-hexabromocyclohexane directly inhibits...
    ≥98%
  • B5874

    Bosutinib

    Src and Abl inhibitor.
    ≥98%
  • C3214

    CID-797718

    Potential PKD binding agent.
    ≥99%
  • T9974

    [Asp371]-Tyrosinase (369-377), human

    Proteasome antigen.
    ≥98%
  • C9670

    Cyromazine

    Triazine, melamine derivative, insect growth regul...
    ≥98%
  • A7202

    AS-604850

    p110γ PI3K inhibitor.
    ≥98%